AM
Highly rated in
7
conditions
Highly rated in
7
conditions

About Dr. Alexander Peter Maxwell

Alexander Maxwell is in Belfast, United Kingdom. Dr. Maxwell is highly rated in 7 conditions, according to our data. His top areas of expertise are Diabetic Nephropathy, Wilson Disease, Chronic Kidney Disease, and Type 1 Diabetes.

His clinical research consists of co-authoring 211 peer reviewed articles in the past 15 years.

Background & Education
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


213 Total Publications

Journal:Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published —March 06, 2021
Erratum to: Using a generic definition of cachexia to understand clinical characteristics and mortality in patients with kidney disease receiving haemodialysis: a longitudinal (pilot) study.


Save this doctor for later
Sign Up
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Belfast Health And Social Care Trust
Belfast, NIR, GB
 0.1 mi
Belfast, NIR, GB 
 0.1 mi
William Mccluggage is in Belfast, United Kingdom. They have been an author on 408 peer reviewed articles in the past 15 years.
Queen's University Belfast
Belfast, NIR, GB
 0.1 mi
Belfast, NIR, GB 
 0.1 mi
Mary Mcmullin is in Belfast, United Kingdom. They have been an author on 169 peer reviewed articles and participated in 2 clinical trials in the past 15 years.
Queen's University Belfast
Belfast, NIR, GB
 0.1 mi
Belfast, NIR, GB 
 0.1 mi
Liam Heaney is in Belfast, United Kingdom. They have been an author on 127 peer reviewed articles and participated in 29 clinical trials in the past 15 years.